In-patient Opioid Use Disorder

Study Summary

Are you between the ages of 18 and 65 with a diagnosis of opioid use disorder and are currently in treatment? Or are you physically dependent on opioids?

Clinilabs is currently seeking participants for a clinical research study evaluating an investigational medication designed to treat opioid withdrawal symptoms in adults.

There is no cost to participate. Those who qualify will receive up to $4,500 in compensation for time and participation. We encourage you to review the participation requirements below.

Study Qualifications

To qualify, participants must meet the following criteria (additional criteria apply):

• Currently in treatment for opioid use disorder or currently an opioid user
• Between the ages of 18 and 65
• Be able and willing to:
  • Remain in the clinic for up to 7 days in-patient stay in Eatontown, NJ
  • Complete on-site pre-qualification testing including, but not limited to, ECG, urinalysis, and bloodwork

Participants must refrain from smoking during the study. During the 7-day inpatient stay, Clinilabs can provide nicotine replacement options—such as patches, gum, or lozenges—if needed. Participants are not allowed any outside visitors. Study compensation may be up to $4,500 for completing all required study visits and laboratory sessions, plus travel reimbursement. Total compensation is dependent on the number of visits completed.

• $200 – Screening visits
• $200 – Baseline visit
• Up to $2,700 – Inpatient stay
• $600 – Outpatient visit
• $750 – Completion bonus
• $50 – Follow-up phone call (day 50 of study)
• Up to $100 travel reimbursement per on-site visit

Study Schedule

1 Screening visit followed by 1 Baseline visit, 7-day In-patient stay, 1 Outpatient follow-up visit, and a later follow-up phone call. The duration of the study may last up to 240 days.

Back to Studies